Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma (Journal of Molecular Medicine, (2018), 96, 12, (1307-1318), 10.1007/s00109-018-1697-7)

WEI-CHOU LINHsu F.-S.Kuo K.-L.SHING-HWA LIUCHIA-TUNG SHUNShi C.-S.HONG-CHIANG CHANGYU-CHIEH TSAILin M.-C.Wu J.-T.Kuo Y.PO-MING CHOWLiao S.-M.Yang S.-P.Hong J.-Y.KUO-HOW HUANG2019-11-122019-11-1220190946-2716https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061510768&doi=10.1007%2fs00109-019-01748-2&partnerID=40&md5=b98b1f496ec031b089e097dda6318feehttps://scholars.lib.ntu.edu.tw/handle/123456789/431129EnglishCorrection to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma (Journal of Molecular Medicine, (2018), 96, 12, (1307-1318), 10.1007/s00109-018-1697-7)erratum10.1007/s00109-019-01748-2307413192-s2.0-85061510768